6/6/2007

The drug safety debate has attracted doctors, lawyers and legislators to comment on FDA operations and proposed legislation to reform the agency. The drug industry supports the Kennedy-Enzi bill requiring more transparency for clinical trials and giving FDA added authority to change drug labels and require post-market studies. Others are calling for a separate center to monitor drugs on the market or a reformed budget to lessen industry ties.

Full Story:
Forbes

Related Summaries